Stock Price Forecast

March 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Geovax Labs Inc chart...

About the Company

geovax labs, inc., (otcqb: govx) is a clinical-stage biotechnology company developing human vaccines against infectious diseases using our modified vaccinia ankara - virus-like particle (mva-vlp) vaccine platform. our development programs are focused on preventive vaccines against hiv, zika virus, hemorrhagic fever viruses (ebola, sudan, marburg, and lassa), and malaria, as well as therapeutic vaccines for chronic hepatitis b infections and cancers. our mva-vlp platform supports in vivo production of non-infectious vlps from the cells of the very person receiving the vaccine, mimicking a natural infection, and stimulating both the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection. for more information, visit www.geovax.com.

CEO

David Dodd

Exchange

NASDAQ

Website

https://www.geovax.com/

$0M

Total Revenue

26

Employees

$4M

Market Capitalization

-0.77

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $GOVX News

Geovax Labs Inc GOVX

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

GeoVax Labs, Inc. (NASDAQ:GOVX) Q4 2023 Earnings Call Transcript

16d ago, source: Hosted on MSN

GeoVax Labs, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome, everyone, to the GeoVax ...

GeoVax Labs (GOVX) Price Target Increased by 1170.83% to 77.78

24d ago, source: Hosted on MSN

Geovax Labs Background Information (This description is provided by the company.) GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases ...

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System

12d ago, source:

Manufacturing Process for Phase 3 and Commercial Production Being Developed for GeoVax MVA-Based Vaccines ATLANTA, GA, March 06, 2024 (GLOBE ...

GeoVax Reports 2023 Year-End Financial Results and Provides Business Update

18d ago, source: Business Insider

via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced its financial ...

GeoVax to Present at the 36th Annual Roth Conference

6d ago, source: Yahoo Finance

ATLANTA, GA, March 12, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire-- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious ...

Earnings call: GeoVax outlines progress in clinical trials and financials

17d ago, source: Investing

GeoVax Labs Inc. (NASDAQ:GOVX) provided updates on its clinical progress and financial status during their Fourth Quarter 2023 Corporate Update Call. CEO David Dodd outlined the company's ...

GeoVax Labs, Inc. (GOVX) Q4 2023 Earnings Call Transcript

18d ago, source: Seeking Alpha

Good afternoon, and welcome, everyone, to the GeoVax Fourth Quarter 2023 Corporate Update Call. My name is Desiree, and I will facilitate today's call. With me are David Dodd, Chairman and CEO ...

GeoVax Reports 2023 Year-End Financial Results and Provides Business Update

18d ago, source: Stockhouse

ATLANTA, GA, Feb. 29, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious ...

GeoVax Labs Inc (GOVX)

18d ago, source: Investing

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like ...

GeoVax, Inc.: GeoVax Reports 2023 Year-End Financial Results and Provides Business Update

18d ago, source: Finanznachrichten

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel therapies and vaccines for solid tumor cancers and many of the world's most threatening infectious diseases.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...